Global Advances and Persistent Disparities in Lung Cancer Treatment

Episode
290
Soundcloud
Share

In this episode of Lung Cancer Considered, host Dr. Narjust Florez moderates a discussion with Dr. Csaba Dégi and Jill Feldman about global policy. The discussion focuses on how global disparities in lung cancer treatment and access to new drugs and medical care affect global health outcomes, and highlights the need for global collaboration to reduce disparities. 

Guest
Narjust Florez
Narjust Florez

MD

Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Jill Feldman
Jill Feldman
EGFR Resisters
Department of Defense Lung Cancer Research Program
Csaba L. Dégi
Csaba L. Dégi

PhD

Faculty of Sociology and Social Work
Researcher, Babes-Bolyai University